CA
NZ
UK
AU
IND
US
Prime Medicine, Inc. (NASDAQ: PRME) shares were trading at USD 4.08 on October 27, 2026, up 13.02%, with a relative volume at time of 2.09. The biotechnology company received clearance of the CTA for PM577a in New Zealand in June 2026, received a final …
Repligen Corporation (NASDAQ: RGEN) shares were trading at USD 173.80 on October 27, 2026, down 3.54%, with a relative volume at time of 2.82. The bioprocessing company closed its acquisition of BioLife Solutions on October 6, opened a training center in Seoul on October …
UroGen Pharma Ltd. (NASDAQ: URGN) shares were trading at USD 33.71 on October 27, 2026, down 0.97%, with a relative volume at time of 2.82. The biotechnology company settled its Jelmyto patent litigation with Teva on June 2, 2026, announced a Notice of Allowance …
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) shares were trading at USD 10.21 on October 27, 2026, up 7.14%, with a relative volume at time of 2.41. The rare disease company repaid its term loans in March 2026, entered a settlement with Commave Therapeutics, announced a …
Aclaris Therapeutics (NASDAQ: ACRS) shares were trading at USD 3.75 on October 27, 2026, down 1.06%, with a relative volume at time of 4.55. The clinical-stage biopharmaceutical company announced primary analysis results from two Phase 1b proof-of-concept trials of its bispecific antibody ATI-052 on …
Avalyn Pharma Inc. (NASDAQ: AVLN) shares were trading at USD 25.40 on October 27, 2026, down 6.41%, with a relative volume at time of 4.81. The clinical-stage biopharmaceutical company completed its initial public offering on May 1, 2026, and filed its Form 10-Q for …
Brookdale Senior Living Inc. (NYSE: BKD) shares were trading at USD 9.60 on October 27, 2026, down 1.64%, with a relative volume at time of 3.43. The senior living operator reported September 2026 occupancy on October 8, 2026, after management held its second quarter …
Centene Corporation (NYSE: CNC) shares were trading at USD 69.01 on October 27, 2026, up 1.44%, with a relative volume at time of 3.62. The managed care company filed its 10-Q for the quarter ended September 30, 2026 on October 27, redeemed its remaining …
Climb Bio (NASDAQ: CLYM) shares were trading at USD 10.03 on October 27, 2026, up 13.85%, with a relative volume at time of 8.08. The clinical-stage biotechnology company completed a private placement in April 2026, entered a $100.0 million at-the-market program in June 2026, …
Glaukos Corporation (NYSE: GKOS) shares were trading at USD 183.85 on October 27, 2026, up 3.13%, with a relative volume at time of 3.95. The ophthalmic pharmaceutical and medical technology company received a permanent J-code for Epioxa on April 15, 2026, filed its 10-Q …
Please wait processing your request...